UK scientists welcome Oxford vaccine efficacy news

World | 23 Nov 2020 4:31 pm

Scientists have welcomed the news from the Oxford-AstraZeneca coronavirus vaccine trial, Sky News reports.

Peter Horby, professor of emerging infectious diseases and global health at the University of Oxford, tweeted: "Oxford jab is far cheaper, and is easier to store and get to every corner of the world than the other two."

Dr Michael Tildesley, associate professor in infectious disease modelling at the University of Warwick, told Times Radio: "It's absolutely excellent news about the Oxford vaccine because this is really the vaccine that the government has pinned a lot of their hopes on in terms of resources – we've ordered 100 million doses of the Oxford vaccine."

Professor Andrew Pollard, director of the Oxford Vaccine Group, said that it was important to begin mass vaccinations as soon as possible.

"The most important thing to get us back to normal is to use these vaccines – all of the vaccines that are going to be available – as soon as possible because once we have protected the vulnerable in the population we will be able to start getting back to normal," he told the BBC Radio 4 Today program.

"We have just got to get on with this as soon as possible."


Search Archive

Advanced Search
January 2021

Today's Standard